• Agenda
    • Programs
    • Plenary Keynotes
    • Breakout Discussions
    • Attendees
    • Speaker Biographies
    • Archives
  • Sponsors & Exhibit
    • Event Features & Attendee Demographics
    • Sponsorship Opportunities
    • Current Sponsors
    • Sponsorship Prospectus
    • Exhibitors 2023 Floorplan
    • Exhibit Services
    • FAQ
    • Sponsor & Exhibitor Portal
  • Downloads
    • Downloads
  • Travel
  • Posters
    • Posters
    • Poster Titles
  • Get Involved
    • Ways to Participate
    • Media Partners
    • Press Info
  • Register
    • Individual Pricing
    • Group Pricing
    • On-Demand
    • Request a Press Pass
Immuno-Oncology Summit 2023

Downloads

2022 The Immuno-Oncology Summit Brochure

The Immuno-Oncology Summit Brochure 2022


2021 The Immuno-Oncology Summit Brochure

The Immuno-Oncology Summit Brochure 2021


2019 The Immuno-Oncology Summit Brochure

The Immuno-Oncology Summit Brochure 2019

2019 Partnering Brochure Download

The Immuno-Oncology Summit Partnering Brochure 2019


2018 The Immuno-Oncology Summit Brochure

The Immuno-Oncology Summit Brochure 2018

IO Summit 2018 Meeting Report

IO Summit 2018 Meeting Report


Oncolytic Virus Immunotherapy Meeting Review 2017

Oncolytic Virus Immunotherapy Meeting Review 2017

2016 The Immuno-Oncology Summit Brochure

The Immuno-Oncology Summit Brochure 2017

2017 ImVacS Brochure

ImVacS 2017 Brochure


2016 The Immuno-Oncology Summit Brochure

The Immuno-Oncology Summit Brochure 2016

Oncolytic-Virus-Immunotherapy-Review

2016 Oncolytic Virus Immunotherapy


Oncolytic Virus Immunotherapy Reading List

Suggested Reading List:
Most Exciting Oncolytic Virotherapy Articles


Outlook YouTube Facebook LinkedIn Twitter
#IOSummit

preliminary Agendas Available
Register Early for Maximum Savings
Event at a Glance
Download 2022 Brochure
Bispecific Antibodies for Cancer Immunotherapy
Advances in CAR T Therapy
AI in Cancer Immunotherapy
Emerging Technologies for IO Targeting & Discovery
Emerging Cell-Based Immunotherapies
Emerging Cell-Based Immunotherapies
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Investing and Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy